Andrew Crofton Selected Research

Biomarkers (Surrogate Marker)

4/2012	Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
1/2012	Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.
1/2012	Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Crofton Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 01/2011
2	Inflammation (Inflammations) 11/2019 - 01/2013
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2013 - 01/2011
2	Dementia (Dementias) 01/2012 - 01/2012
1	Fibrosis (Cirrhosis) 11/2019
1	Hemorrhage 02/2016
1	Wounds and Injuries (Trauma) 02/2016
1	Memory Disorders (Memory Loss) 04/2012
1	Cognitive Dysfunction 01/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 04/2012 - 01/2012
2	CopperIBA 01/2012 - 01/2011
2	IronIBA 01/2012 - 01/2011
1	Hemostatics (Antihemorrhagics)IBA 02/2016
1	ChitosanIBA 02/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Histones (Histone)IBA 04/2012
1	Heme (Haem)IBA 01/2012
1	Blood Proteins (Serum Proteins)IBA 01/2012
1	ZincIBA 01/2011

Therapy/Procedure

1	Nephrectomy 11/2019